Gavi Outlines Key Priorities to Achieve African Union Vision of Expanding Vaccine Manufacturing Capacity
Gavi, the Vaccine Alliance today published a 10-point plan outlining key priorities to achieve the African Union (AU) vision of sustainably expanding vaccine manufacturing capacity across Africa by 2040. The plan is a response to the AU call to action for Gavi and other stakeholders to concretely support supply security on the continent.
Developed following several months of technical consultation with the AU and Africa Centres for Disease Control and Prevention (ACDC), as well as a wide range of supporting stakeholders including civil society organizations, WHO, UNICEF, Coalition for Epidemic Preparedness Innovations (CEPI), governments of Germany, India and Indonesia, European Commission, Bill & Melinda Gates Foundation, European Investment Bank, GIZ, International Finance Corporation, and US International Development Finance Corporation, the plan proposes actions for Gavi and other international organizations, private sector, G7 Development Ministers, and African countries to contribute to a new business model that sustainably invests across the full Classified as InternalClassified as Interna value chain of the African vaccine industry, in a manner that is consistent with both the AU’s vision and G7 policy commitments.
“For 22 years, as the largest buyer of vaccines in the world, Gavi has worked closely with African countries and manufacturers to favorably shape the market for essential routine and outbreak vaccines,” said Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance.
Photo courtesy Dominic Chavez/World Bank.
- Health Care